Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-01-14

Clinical Trial Update: Helping Ovarian Cancer Patients Cope With Their Illness (HOPE) [NA]

View source ↗

Summary

The HOPE trial for recurrent ovarian carcinoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Ovarian Carcinoma | NA | Status: SUSPENDED